← Stack Research Tool

Pair page

GHK Basic with GHK-Cu

Mechanism-tag overlap and published literature for GHK Basic and GHK-Cu, pulled verbatim from each Kalios compound profile. Kalios is a literature reference, not a recommendation.

Mechanism overlap

Mechanism tags are verbatim labels on each compound's profile. Generic tags ("peptide", "small-molecule", "research-chemical") are excluded from this overlap view. Tags are descriptive — not an inference about combined effect.

GHK BASIC GHK-CU 2 UNIQUE TAGS 2 UNIQUE TAGS 0 SHARED
GHK Basic unique matrikine-cosmetic-signaling-peptidetripeptide
Shared none
GHK-Cu unique connective-tissuecopper-tripeptide-skin

Co-administration notes from the literature

Verbatim summary text pulled from each compound's profile data. Researchers studying GHK Basic and GHK-Cu have published these mechanism-level observations. Not a co-administration recommendation.

Evidence level: mechanistic only

The natural comparator and the more evidence-backed alternative. Users sometimes sequentially trial copper-free GHK and GHK-Cu to compare response. Concurrent stacking is uncommon and largely redundant since both forms converge in vivo after copper coordination.

Quick facts

GHK Basic

RouteTopical (cosmetic) / research SubQ
Half-lifeMinutes (plasma, extrapolated)
FDA statusCosmetic ingredient only
WADANot specifically named; plausibly S0 by analogy
Full GHK Basic profile →

GHK-Cu

RouteTopical > SubQ
Half-lifeMinutes (plasma); longer topical residence
FDA statusCosmetic ingredient; Category 2 for injection
WADANot specifically named; plausibly S0 by analogy
Full GHK-Cu profile →

Literature table

Classified references from each compound profile. Click a column header to sort. Click a PMID to open PubMed. Findings are quoted verbatim from each profile's literature_summary; nothing here is added or interpreted.

Year Compound Source Finding
2012GHK BasicChoi HR, Kang YA, Ryoo SJ, Shin JW, Na JI, Huh CH, Park KC. Stem cell recovering effect of copper-free GHK in skin. J Pept Sci. 2012;18(11):685-690. doi:10.1002/psc.2455. (Key paper for copper-free GHK: stem-cell preservation in human skin equivalents without copper coordination…human study
2011GHK BasicHostynek JJ, Dreher F, Maibach HI. Human skin penetration of a copper tripeptide in vitro as a function of skin layer. Inflamm Res. 2011;60(1):79-86. PMID: 20835751. (Topical penetration data — relevant to cosmetic copper-free formulations.) PMID 20835751preclinical, in vitro
1988GHK BasicMaquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺. FEBS Lett. 1988;238(2):343-346. PMID: 3169264. (Foundational collagen-stimulation paper… PMID 3169264preclinical, in vitro
2017GHK BasicPickart L, Vasquez-Soltero JM, Margolina A. The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline. Brain Sci. 2017;7(2):20. PMID: 28212278. PMID 28212278mechanism / discovery
2008GHK BasicBeretta G, Arlandini E, Artali R, Anton JM, Maffei Facino R. Acrolein sequestering ability of the endogenous tripeptide glycyl-histidyl-lysine (GHK): characterization of conjugation products by ESI-MSn and theoretical calculations. J Pharm Biomed Anal. 2008;47(3):596-602.mechanism / discovery
1973GHK BasicPickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat New Biol. 1973;243(124):85-87. PMID: 4351857. (Original isolation of GHK from human plasma.) PMID 4351857mechanism / discovery
2026GHK BasicWADA Prohibited List 2026. World Anti-Doping Agency. wada-ama.org.regulatory / registry
2025GHK BasicFDA. Bulk Drug Substances Nominated for Use in Compounding — 503A and 503B Categories. FDA.gov. Updated 2025-2026.regulatory / registry
2018GHK BasicPickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. PMID: 29986520. (Comprehensive modern review; notes copper-dependent vs copper-independent activities.) PMID 29986520research article
2015GHK BasicPickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. PMID: 26236730. PMID 26236730research article
2012GHK BasicPickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging. Oxid Med Cell Longev. 2012;2012:324832. PMID: 22666521. PMID 22666521research article
2012GHK BasicTrapaidze A, Hureau C, Bal W, Winterhalter M, Faller P. Thermodynamic study of Cu²⁺ binding to the DAHK and GHK peptides by isothermal titration calorimetry (ITC) with the weaker competitor glycine. J Biol Inorg Chem. 2012;17(1):37-47. PMID: 21748269. (Quantifies the very high c… PMID 21748269research article
1995GHK-CuBuffoni F, Pino R, Dal Pozzo A. Effect of tripeptide-copper complexes on the process of healing of cutaneous wounds in mice. Arch Int Pharmacodyn Ther. 1995;330(3):345-360. PMID: 9060874. PMID 9060874preclinical, in vivo
1993GHK-CuMaquart FX, Bellon G, Chaqour B, Wegrowski J, Patt LM, Trachy RE, et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺ in rat experimental wounds. J Clin Invest. 1993;92(5):2368-2376. PMID: 8227353. PMID 8227353preclinical, in vivo
2007GHK-CuPyo HK, Yoo HG, Won CH, Lee SH, Kang YJ, Eun HC, Cho KH, Kim KH. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007;30(7):834-839. PMID: 17702486. PMID 17702486preclinical, in vitro
2012GHK-CuCampbell JD, McDonough JE, Zeskind JE, Hackett TL, Pechkovsky DV, Brandsma CA, et al. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Med. 2012;4(8):67. PMID: 22937864. PMID 22937864mechanism / discovery
2026GHK-CuWADA Prohibited List 2026. World Anti-Doping Agency. wada-ama.org.regulatory / registry
2025GHK-CuFDA. Bulk Drug Substances That Raise Significant Safety Risks (Category 2) Under Section 503A / 503B. FDA.gov. Updated 2025-2026.regulatory / registry
2009GHK-CuKang YA, Choi HR, Na JI, Huh CH, Kim MJ, Youn SW, Kim KH, Park KC. Copper-GHK increases integrin expression and p63 positivity by keratinocytes. Arch Dermatol Res. 2009;301(4):301-306. PMID: 19129717. PMID 19129717research article
2008GHK-CuMazurowska L, Mojski M. Biological activities of selected peptides: skin penetration ability of copper complexes with peptides. J Cosmet Sci. 2008;59(1):59-69. PMID: 18350230. PMID 18350230research article

Related pair pages

More research context

Frequently asked

Have GHK Basic and GHK-Cu been studied together?

Researchers have published mechanistic-level co-administration discussion of GHK Basic and GHK-Cu. No human co-administration trials are catalogued in the Kalios profiles. The pair page lists each compound's classified literature; full citations sit on each individual profile.

What mechanisms do GHK Basic and GHK-Cu share?

GHK Basic and GHK-Cu do not share a specific mechanism tag on their Kalios profiles. They appear on the same pair page because at least one profile lists the other in its co-administration data.

What is the FDA status of GHK Basic and GHK-Cu?

GHK Basic: Cosmetic ingredient only. GHK-Cu: Cosmetic ingredient; Category 2 for injection. FDA-status text is pulled verbatim from each compound profile. See /fda-pcac-2026.html for the broader FDA Pharmacy Compounding Advisory Committee context.

Where can I find the full research on GHK Basic and GHK-Cu?

Full citation lists, dosing tables from the literature, reconstitution data, and the FDA / WADA status are on the individual compound profiles: the GHK Basic profile and the GHK-Cu profile. The Kalios Stack Research Tool hub lists every compound covered.

Last updated: April 2026